knowledge -WSS

knowledge

author：knowledge 2025-09-30 14:10:11 - browse：49

Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT — Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： 2023 Nobel Prize in Medicine goes to Karikó and Weissman

WSS

Why CTE doesn’t keep Americans from enjoying the Super Bowl

A single Democrat is willing to weaken Medicare negotiation power

Problems with a popular proposal to regulate AI in health care

New oral drug delivery patch is modeled after octopus tentacles

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Gene therapy for Afghan refugees’ infant will be fully covered

focus

knowledge

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Updated Covid vaccine has 54% effectiveness, new study suggests

United colonoscopy coverage change 'may cost lives,' doctors say

Stop Congress from blocking public access to science

Apple is now the first public company to be valued at $3 trillion

Why CTE doesn’t keep Americans from enjoying the Super Bowl

New air purifier tech could be key to improving indoor air quality

Gene therapy for Afghan refugees’ infant will be fully covered

United colonoscopy coverage change 'may cost lives,' doctors say

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

focus

Study points to new risk in gene therapy death of Terry Horgan

Some top drug companies are starting to take action on climate

European officials brace for rough respiratory virus season

The stability of $0 premiums in Medicare Advantage

The CDC's new social media misinformation war

2023 Nobel Prize in Medicine goes to Karikó and Weissman

leisure time

focus

hotspot

knowledge